Palantir’s software is leading the industry, with its stock trading at a higher valuation than Nvidia’s. Since 2023, Palantir has risen 2,640% compared to Nvidia’s 1,130%. Palantir’s AI-powered data analytics software is dominating its industry, with revenue growing 63% year over year to $1.12 billion in Q3.
Nvidia, on the other hand, is facing rising competition in its segment, particularly from rival AMD and Alphabet offering TPUs to Meta Platforms. Despite the competition, Nvidia’s revenue rose 62% year over year in Q3. While Palantir’s business is dominant, Nvidia’s stock has a more reasonable valuation for its growth levels.
Investors are debating whether to invest in Nvidia or Palantir. While Palantir’s business is strong, its stock has a higher premium compared to Nvidia. Nvidia, with a more reasonable valuation, may be the better investment option in 2026. The Motley Fool Stock Advisor team has identified 10 best stocks, excluding Nvidia, that could produce significant returns.
Keithen Drury holds positions in Alphabet, Broadcom, Meta Platforms, and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Meta Platforms, Nvidia, and Palantir Technologies, and recommends Broadcom. 1. In a groundbreaking study, researchers have discovered a new species of dinosaur in Argentina. The dinosaur, named Llukalkan aliocranianus, had a unique skull structure and large teeth, indicating it was a powerful predator. This finding sheds new light on the diversity of dinosaurs that roamed the Earth millions of years ago.
2. The United Nations has reported that global food prices have reached their highest level in seven years. This increase is largely due to supply chain disruptions caused by the COVID-19 pandemic, as well as extreme weather events affecting crop yields. The rise in food prices is a growing concern for vulnerable populations worldwide.
3. Scientists have successfully developed a new blood test that can detect over 50 types of cancer before symptoms appear. The test, known as CancerSEEK, analyzes DNA and protein biomarkers in the blood to identify early signs of cancer. Early detection through this test could significantly improve cancer survival rates.
4. A recent study has found that regular exercise can reduce the risk of severe COVID-19 outcomes, including hospitalization and death. The study, which analyzed data from over 50,000 COVID-19 patients, showed that those who exercised regularly were less likely to experience severe symptoms. Staying active could be a key factor in mitigating the impact of the virus.
Read more at Nasdaq: Is Palantir or Nvidia the Best AI Stock for 2026?